Abstract
Magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) provide metabolic information on the musculoskeletal system, thus helping to understand the biochemical and pathophysiological nature of numerous diseases. In particular, MRS has been used to study the energy metabolism of muscular tissue since the very beginning of magnetic resonance examinations in humans when small-bore magnets for studies of the limbs became available. Even more than in other organs, the observation of non-proton-nuclei was important in muscle tissue. Spatial localization was less demanding in these studies, however, high temporal resolution was necessary to follow metabolism during exercise and recovery. The observation of high-energy phosphates during and after the application of workload gives insight into oxidative phosphorylation, a process that takes place in the mitochondria and characterizes impaired mitochondrial function. New applications in insulin-resistant patients followed the development of volume-selective 1H-MRS in whole-body magnets. Nowadays, multinuclear MRS and MRSI of the musculoskeletal system provide several windows to vital biochemical pathways noninvasively. It is shown how MRS and MRSI have been used in numerous diseases to characterize an involvement of the muscular metabolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 1H:
-
1-Hydrogen, protons
- 13C:
-
13-Carbon
- 19F:
-
19-Fluor
- 23Na:
-
23-Sodium
- 31P:
-
31-Phosphorus
- ADP:
-
Adenosinediphosphate
- AOD:
-
Arterial occlusive disease
- ATP:
-
Adenosinetriphosphate
- BMD:
-
Becker muscle dystrophies
- CPEO:
-
Chronic progressive external ophthalmoplegia
- CPOD:
-
Chronic obstructive pulmonary disease
- CSI:
-
Chemical shift imaging
- DMD:
-
Duchenne muscle dystrophies
- DNA:
-
Deoxyribonucleic acid
- EMCL:
-
Extramyocellular lipids
- FSHD:
-
Facioscapulohumeral muscular dystrophy
- G6P:
-
Glucose-6-phosphate
- GHD:
-
Growth hormone deficiency
- GPCh:
-
Glycerophosphocholine
- GPEt:
-
Glycerophosphoethanolamine
- IMCL:
-
Intramyocellular lipids
- ISIS:
-
Image-selected in vivo spectroscopy
- KSS:
-
Kearns-Sayre syndrome
- LGMD:
-
Limb girdle muscular dystrophy
- LHON:
-
Leber’s hereditary optic neuropathy
- MELAS:
-
Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes
- MERRF:
-
Myoclonus epilepsy with ragged red fibers
- MH:
-
Malignant hyperthermia
- MIDD:
-
Maternally inherited diabetes and deafness
- MRI:
-
Magnetic resonance imaging
- MRS:
-
Magnetic resonance spectroscopy
- MRSI:
-
Magnetic resonance spectroscopic imaging
- NADH:
-
Nicotinamide adenine dinucleotide
- NARP:
-
Neuropathy, ataxia, and retinitis pigmentosa
- NIDDM:
-
Non-insulin-dependent-diabetes-mellitus
- NIRS:
-
Near infrared spectroscopy
- OPMD:
-
Oculopharyngeal muscular dystrophy
- PAD:
-
Peripheral arterial disease
- PCh:
-
Phosphocholine
- PCr:
-
Phosphocreatine
- PDE:
-
Phosphodiester
- PEt:
-
Phosphoethanolamine
- PFK:
-
Phosphofructokinase
- pH:
-
Concentration of hydrogen
- Pi:
-
Inorganic phosphate
- PME:
-
Phosphomonoester
- PRESS:
-
Point resolved spectroscopy
- QMAX:
-
Apparent maximum rate of oxidative ATP synthesis
- SNR:
-
Signal-to-noise ratio
- STEAM:
-
Stimulated echo acquisition mode
- TCA:
-
Tricarboxylic acid cycle
- TE:
-
Echo time
- TMA:
-
Trimethyl ammonium containing metabolites
- TR:
-
Repetition time
- tRNA:
-
Transfer ribonucleic acid
- VEGF:
-
Vascular endothelial growth factor
- VO2max:
-
Maximal oxygen uptake
References
Adamopoulos S, Coats AJ, Brunotte F, Arnolda L, Meyer T, Thompson CH, Dunn JF, Stratton J, Kemp GJ, Radda GK, Rajagopalan B (1993) Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 21:1101–1106
Akima H, Foley JM, Prior BM, Dudley GA, Meyer RA (2002) Vastus lateralis fatigue alters recruitment of musculus quadriceps femoris in humans. J Appl Physiol 92:679–684
Akman HO, Davidzon G, Tanji K, Macdermott EJ, Larsen L, Davidson MM, Haller RG, Szczepaniak LS, Lehman TJ, Hirano M, DiMauro S (2010) Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene. Neuromuscul Disord 20:397–402
Argov Z (1998) Functional evaluation techniques in mitochondrial disorders. Eur Neurol 39:65–71
Argov Z, Bank WJ (1991) Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Ann Neurol 30:90–97
Argov Z, Bank WJ, Maris J, Peterson P, Chance B (1987) Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 37:257–262
Argov Z, De Stefano N, Arnold DL (1996) ADP recovery after a brief ischemic exercise in normal and diseased human muscle—a 31P MRS study. NMR Biomed 9:165–172
Argov Z, De SN, Taivassalo T, Chen J, Karpati G, Arnold DL (1997) Abnormal oxidative metabolism in exercise intolerance of undetermined origin. Neuromuscul Disord 7:99–104
Argov Z, Taivassalo T, De SN, Genge A, Karpati G, Arnold DL (1998) Intracellular phosphates in inclusion body myositis—a 31P magnetic resonance spectroscopy study. Muscle Nerve 21:1523–1525
Argov Z, Lofberg M, Arnold DL (2000) Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve 23:1316–1334
Arnold DL, Matthews PM, Radda GK (1984) Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med 1:307–315
Arnold DL, Taylor DJ, Radda GK (1985) Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 18:189–196
Bajaj M, Baig R, Suraamornkul S, Hardies LJ, Coletta DK, Cline GW, Monroy A, Koul S, Sriwijitkamol A, Musi N, Shulman GI, DeFronzo RA (2010) Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95:1916–1923
Banerjee B, Sharma U, Balasubramanian K, Kalaivani M, Kalra V, Jagannathan NR (2010) Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. Magn Reson Imaging 28:698–707
Barbiroli B, Funicello R, Ferlini A, Montagna P, Zaniol P (1992) Muscle energy metabolism in female DMD/BMD carriers: a 31P-MR spectroscopy study. Muscle Nerve 15:344–348
Barbiroli B, Montagna P, Cortelli P, Iotti S, Lodi R, Barboni P, Monari L, Lugaresi E, Frassineti C, Zaniol P (1995) Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation. Neurology 45:1364–1369
Barbiroli B, Frassineti C, Martinelli P, Iotti S, Lodi R, Cortelli P, Montagna P (1997) Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell Mol Biol 43:741–749
Barnes PR, Taylor DJ, Kemp GJ, Radda GK (1993) Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 56:679–683
Baumgartner I, Thoeny HC, Kummer O, Roefke C, Skjelsvik C, Boesch C, Kreis R (2005) Leg ischemia: assessment with MR angiography and spectroscopy. Radiology 234:833–841
Beckmann N, Seelig J, Wick H (1990) Analysis of glycogen storage disease by in vivo 13C NMR: comparison of normal volunteers with a patient. Magn Reson Med 16:150–160
Befroy DE, Shulman GI (2011) Magnetic resonance spectroscopy studies of human metabolism. Diabetes 60:1361–1369
Befroy DE, Rothman DL, Petersen KF, Shulman GI (2012) 31P-magnetization transfer magnetic resonance spectroscopy measurements of in vivo metabolism. Diabetes 61:2669–2678
Beloueche-Babari M, Workman P, Leach MO (2011) Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agents. Cell Cycle 10:2883–2893
Bendahan D, Confort-Gouny S, Kozak-Ribbens G, Cozzone PJ (1992a) 31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle. Biochem Biophys Res Commun 185:16–21
Bendahan D, Desnuelle C, Vanuxem D, Confort-Gouny S, Figarella-Branger D, Pellissier JF, Kozak-Ribbens G, Pouget J, Serratrice G, Cozzone PJ (1992b) 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42:1203–1208
Bendahan D, Kozak-Ribbens G, Rodet L, Confort-Gouny S, Cozzone PJ (1998) 31Phosphorus magnetic resonance spectroscopy characterization of muscular metabolic anomalies in patients with malignant hyperthermia: application to diagnosis. Anesthesiology 88:96–107
Bendahan D, Kozak-Ribbens G, Confort-Gouny S, Ghattas B, Figarella-Branger D, Aubert M, Cozzone PJ (2001) A noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia. Anesth Analg 93:683–689
Bertocci LA, Haller RG, Lewis SF (1993) Muscle metabolism during lactate infusion in human phosphofructokinase deficiency. J Appl Physiol 74:1342–1347
Boesch C (1999) Molecular aspects of magnetic resonance imaging and spectroscopy. Mol Aspects Med 20:185–318
Boesch C (2007) Musculoskeletal spectroscopy. J Magn Reson Imaging 25:321–338
Boesch C, Kreis R (2001) Dipolar coupling and ordering effects observed in magnetic resonance spectra of skeletal muscle. NMR Biomed 14:140–148
Boesch C, Slotboom H, Hoppeler H, Kreis R (1997) In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37:484–493
Boesch C, Machann J, Vermathen P, Schick F (2006) Role of proton MR for the study of muscle lipid metabolism. NMR Biomed 19:968–988
Boss A, Broskey NT, Kreis R, Amati F, Boesch C (2013) In vivo oxidative capacity vs. mitochondrial volume density in skeletal muscle of age-matched, elderly athletes and sedentary subjects—A matter of function and content. Proc Intl Soc Magn Reson Med 21:362
Brillault-Salvat C, Giacomini E, Wary C, Peynsaert J, Jouvensal L, Bloch G, Carlier PG (1997) An interleaved heteronuclear NMRI-NMRS approach to non-invasive investigation of exercising human skeletal muscle. Cell Mol Biol 43:751–762
Cardoso M, Shoubridge E, Arnold D, Leveille M, Prud’Homme M, St-Louis G, Vinay P (1988) NMR monitoring of the energy status of skeletal muscle during hemodialysis using acetate. Clin Invest Med 11:292–296
Carey PE, Halliday J, Snaar JE, Morris PG, Taylor R (2003) Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. Am J Physiol 284:E688–E694
Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Styles P, Taylor DJ (2002) Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain 125:1635–1645
Chance B, Eleff S, Leigh JS, Sokolow D, Sapega A (1981) Mitochondrial regulation of phophocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study. Proc Natl Acad Sci USA 78:6714–6718
Chance B, Eleff S, Bank W, Leigh JS, Warnell R (1982) 31P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle. Proc Natl Acad Sci USA 79:7714–7718
Chance B, Leigh JS, Clark BJ, Maris J, Kent J, Nioka S, Smith D (1985) Control of oxidative meatbolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci USA 82:8384–8388
Chance B, Leigh JS, Kent J, McCully K, Nioka S, Clark BJ, Maris JM, Graham T (1986) Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. Proc Natl Acad Sci USA 83:9458–9462
Chang G, Wang L, Cardenas-Blanco A, Schweitzer ME, Recht MP, Regatte RR (2010) Biochemical and physiological MR imaging of skeletal muscle at 7 Tesla and above. Semin Musculoskelet Radiol 14:269–278
Chilibeck PD, McCreary CR, Marsh GD, Paterson DH, Noble EG, Taylor AW, Thompson RT (1998) Evaluation of muscle oxidative potential by 31P-MRS during incremental exercise in old and young humans. Eur J Appl Physiol 78:460–465
Chinnery PF, Taylor DJ, Brown DT, Manners D, Styles P, Lodi R (2000) Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol 47:381–384
Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Stahl-Hallengren C, Richards S, Thomas EL, Hamilton G, Bell JD, Lundberg IE, Scott DL (2007) Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 57:694–702
Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240–246
Coen PM, Jubrias SA, Distefano G, Amati F, Mackey DC, Glynn NW, Manini TM, Wohlgemuth SE, Leeuwenburgh C, Cummings SR, Newman AB, Ferrucci L, Toledo FG, Shankland E, Conley KE, Goodpaster BH (2013) Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. J Gerontol A Biol Sci Med Sci 68:447–455
Conley KE, Jubrias SA, Esselman PC (2000) Oxidative capacity and ageing in human muscle. J Physiol 526:203–210
Cortelli P, Montagna P, Avoni P, Sangiorgi S, Bresolin N, Moggio M, Zaniol P, Mantovani V, Barboni P, Barbiroli B (1991) Leber’s hereditary optic neuropathy: genetic, biochemical, and phosphorus magnetic resonance spectroscopy study in an Italian family. Neurology 41:1211–1215
Costa FM, Canella C, Gasparetto E (2011) Advanced magnetic resonance imaging techniques in the evaluation of musculoskeletal tumors. Radiol Clin North Am 49:1325–1358
Crilley JG, Bendahan D, Boehm EA, Styles P, Rajagopalan B, Wordsworth P, Clarke K (2007) Investigation of muscle bioenergetics in the Marfan syndrome indicates reduced metabolic efficiency. J Cardiovasc Magn Reson 9:709–717
Davies RC, Eston RG, Fulford J, Rowlands AV, Jones AM (2011) Muscle damage alters the metabolic response to dynamic exercise in humans: a 31P-MRS study. J Appl Physiol 111:782–790
Dawson MJ, Gadian DG, Wilkie DR (1977) Contraction and recovery of living muscles studied by 31-P nuclear magnetic resonance. J Physiol 267:703–735
de Bisschop E, Allein S, Van der Niepen P, Verbeelen D, Luypaert R, Osteaux M, Malaisse W (1997) Effect of amino acid administration on uremic muscle metabolism: a 31P-spectroscopy study. Kidney Int 51:1182–1187
de Blecourt AC, Wolf RF, van Rijswijk MH, Kamman RL, Knipping AA, Mooyaart EL (1991) In vivo 31P magnetic resonance spectroscopy (MRS) of tender points in patients with primary fibromyalgia syndrome. Rheumatol Int 11:51–54
De Feyter HM, van den Broek NM, Praet SF, Nicolay K, van Loon LJ, Prompers JJ (2008) Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur J Endocrinol 158:643–653
Decombaz J, Schmitt B, Ith M, Decarli B, Diem P, Kreis R, Hoppeler H, Boesch C (2001) Post-exercise fat intake repletes intramyocellular lipids, but no faster in trained than in sedentary subjects. Am J Physiol 281:R760–R769
deKerviler E, Leroy-Willig A, Jehenson P, Duboc D, Eymard B, Syrota A (1991) Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and 31-P spectroscopy. Radiology 181:259–264
DiMauro S (2006) Mitochondrial myopathies. Curr Opin Rheumatol 18:636–641
Duboc D, Jehenson P, Tran DS, Marsac C, Syrota A, Fardeau M (1987) Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis. Neurology 37:663–671
Duboc D, Jehenson P, Tamby JF, Payen JF, Syrota A, Guerin F (1991) Abnormalities of the skeletal muscle in hypertrophic cardiomyopathy. Spectroscopy using phosphorus-31 nuclear magnetic resonance. Arch Mal Coeur Vaiss 84:185–188
Dudley CR, Taylor DJ, Ng LL, Kemp GJ, Ratcliffe PJ, Radda GK, Ledingham JG (1990) Evidence for abnormal Na+/H+ antiport activity detected by phosphorus nuclear magnetic resonance spectroscopy in exercising skeletal muscle of patients with essential hypertension. Clin Sci 79:491–497
Edwards RH, Wilkie DR, Dawson MJ, Gordon RE, Shaw D (1982) Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet 1:725–731
Eleff S, Kennaway NG, Buist NRM, Darley-Usmar VM, Bank WJ, Chance B (1984) 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 81:3529–3533
Erkintalo M, Bendahan D, Mattei JP, Fabreguettes C, Vague P, Cozzone PJ (1998) Reduced metabolic efficiency of skeletal muscle energetics in hyperthyroid patients evidenced quantitatively by in vivo phosphorus-31 magnetic resonance spectroscopy. Metabolism 47:769–776
Esterhammer R, Schocke M, Gorny O, Posch L, Messner H, Jaschke W, Fraedrich G, Greiner A (2008) Phosphocreatine kinetics in the calf muscle of patients with bilateral symptomatic peripheral arterial disease during exhaustive incremental exercise. Mol Imaging Biol 10:30–39
Fayad LM, Barker PB, Bluemke DA (2007) Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol 11:240–245
Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA (2012) Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology 265:340–356
Finanger EL, Russman B, Forbes SC, Rooney WD, Walter GA, Vandenborne K (2012) Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 23:1–10, ix
Flaherty JT, Weisfeldt ML, Bulkley BH, Gardner TJ, Gott VL, Jacobus WE (1982) Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation 65:561–570
Fleischman A, Kron M, Systrom DM, Hrovat M, Grinspoon SK (2009) Mitochondrial function and insulin resistance in overweight and normal-weight children. J Clin Endocrinol Metab 94:4923–4930
Forbes SC, Paganini AT, Slade JM, Towse TF, Meyer RA (2009) Phosphocreatine recovery kinetics following low- and high-intensity exercise in human triceps surae and rat posterior hindlimb muscles. Am J Physiol 296:R161–R170
Forsen S, Hoffman RA (1963) Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 39:2892–2901
Frostick SP, Taylor DJ, Dolecki MJ, Radda GK (1992) Human muscle cell denervation: the results of a 31-phosphorus magnetic resonance spectroscopy study. J Hand Surg Br 17:33–45
Gadian D, Ross B, Bore P, Radda G, Hockaday J, Taylor D (1981) Examination of a myopathy by phosphorus nuclear magnetic resonance. Lancet 2:774–775
Glunde K, Bhujwalla ZM (2011) Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol 38:26–41
Glunde K, Bhujwalla ZM, Ronen SM (2011) Choline metabolism in malignant transformation. Nat Rev Cancer 11:835–848
Gold R, Seibel P, Reinelt G, Schindler R, Landwehr P, Beck A, Reichmann H (1996) Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q. Eur Neurol 36:191–196
Grehl T, Muller K, Vorgerd M, Tegenthoff M, Malin JP, Zange J (1998) Impaired aerobic glycolysis in muscle phosphofructokinase deficiency results in biphasic post-exercise phosphocreatine recovery in 31P magnetic resonance spectroscopy. Neuromuscul Disord 8:480–488
Grehl T, Fischer S, Muller K, Malin JP, Zange J (2007) A prospective study to evaluate the impact of 31P-MRS to determinate mitochondrial dysfunction in skeletal muscle of ALS patients. Amyotroph Lateral Scler 8:4–8
Greiner A, Esterhammer R, Messner H, Biebl M, Muhlthaler H, Fraedrich G, Jaschke WR, Schocke MF (2006) High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. J Vasc Surg 43:978–986
Gruetter R, Kaelin P, Boesch C, Martin E, Werner B (1990) Non-invasive P-31 magnetic resonance spectroscopy revealed McArdle disease in an asymptomatic child. Eur J Pediatr 149:483–486
Gruetter R, Prolla TA, Shulman RG (1991) 13C NMR visibility of rabbit muscle glycogen in vivo. Magn Reson Med 20:327–332
Guis S, Jouglard J, Kozak-Ribbens G, Figarella-Branger D, Vanuxem D, Pellissier JF, Cozzone PJ (2001) Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment. J Rheumatol 28:1405–1406
Guis S, Mattei JP, Pellissier JF, Nicoli F, Figarella-Branger D, Le Fur Y, Kaplanski G, Pelletier J, Harle JR, Cozzone PJ, Bendahan D (2004) MRI and 31PMR spectroscopy investigations of muscle function disclose no abnormality in macrophagic myofasciitis. J Rheumatol 31:2313–2314
Guis S, Mattei JP, Cozzone PJ, Bendahan D (2005) Pathophysiology and clinical presentations of rhabdomyolysis. Joint Bone Spine 72:382–391
Guis S, Figarella-Branger D, Mattei JP, Nicoli F, Le Fur Y, Kozak-Ribbens G, Pellissier JF, Cozzone PJ, Amabile N, Bendahan D (2006) In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects. Arthritis Rheum 55:551–557
Guis S, Mattei JP, Bendahan D (2012) Toxic myopathies. Joint Bone Spine. doi:10.1016/j.jbspin.2012.10.008
Gupta RK, Mittal RD, Agarwal KN, Agarwal DK (1994) Muscular sufficiency, serum protein, enzymes and bioenergetic studies (31-phosphorus magnetic resonance spectroscopy) in chronic malnutrition. Acta Paediatr 83:327–331
Hagspiel KD, von Weymarn C, McKinnon G, Haldemann R, Marincek B, von Schulthess GK (1992) Effect of hypothyroidism on phosphorus metabolism in muscle and liver: in vivo P-31 MR spectroscopy study. J Magn Reson Imaging 2:527–532
Harris RC, Hultman E, Kaijser L, Nordesjo LO (1975) The effect of circulatory occlusion on isometric exercise capacity and energy metabolism of the quadriceps muscle in man. Scand J Clin Lab Invest 35:87–95
Haselgrove JC, Subramanian VH, Leigh JS, Gyulai L, Chance B (1982) In vivo one-dimensional imaging of phosphorus metabolites by phosphorus-31 nuclear magnetic resonance. Science 220:1170
Hayes DJ, Hilton-Jones D, Arnold DL, Galloway G, Styles P, Duncan J, Radda GK (1985) A mitochondrial encephalomyopathy. A combined 31P magnetic resonance and biochemical investigation. J Neurol Sci 71:105–118
Heiman-Patterson TD, Argov Z, Chavin JM, Kalman B, Alder H, DiMauro S, Bank W, Tahmoush AJ (1997) Biochemical and genetic studies in a family with mitochondrial myopathy. Muscle Nerve 20:1219–1224
Hickman PF, Kemp GJ, Thompson CH, Salisbury AJ, Wade K, Harris AL, Radda GK (1995) Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study. Br J Cancer 72:998–1003
Hollingsworth KG, Jones DE, Taylor R, Blamire AM, Newton JL (2010) Impaired cardiovascular response to standing in chronic fatigue syndrome. Eur J Clin Invest 40:608–615
Horska A, Fishbein KW, Fleg JL, Spencer RG (2000) The relationship between creatine kinase kinetics and exercise intensity in human forearm is unchanged by age. Am J Physiol 279:E333–E339
Hoult DI, Busby SJW, Gadian DG, Radda GK, Richards RE, Seeley PJ (1974) Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 252:285–287
Hsieh TJ, Wang CK, Chuang HY, Jong YJ, Li CW, Liu GC (2007) In vivo proton magnetic resonance spectroscopy assessment for muscle metabolism in neuromuscular diseases. J Pediatr 151:319–321
Hsieh TJ, Jaw TS, Chuang HY, Jong YJ, Liu GC, Li CW (2009) Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr 33:150–154
Ith M, Huber PM, Egger A, Schmid JP, Kreis R, Christ E, Boesch C (2010) Standardized protocol for a depletion of intramyocellular lipids (IMCL). NMR Biomed 23:532–538
Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113–1119
Jehenson P, Duboc D, Bloch G, Fardeau M, Syrota A (1991) Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy. Neuromuscul Disord 1:99–101
Jenni S, Oetliker C, Allemann S, Ith M, Tappy L, Wuerth S, Egger A, Boesch C, Schneiter PH, Diem P, Christ E, Stettler C (2008) Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus—a prospective single-blinded randomised crossover trial. Diabetologia 51:1457–1465
Jensen KE, Jakobsen J, Thomsen C, Henriksen O (1990) Improved energy kinetics following high protein diet in McArdle’s syndrome. A 31P magnetic resonance spectroscopy study. Acta Neurol Scand 81:499–503
Jeppesen TD, Quistorff B, Wibrand F, Vissing J (2007) 31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy. J Neurol 254:29–37
Jones DE, Hollingsworth KG, Taylor R, Blamire AM, Newton JL (2010) Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome. J Intern Med 267:394–401
Kaminsky P, Robin-Lherbier B, Brunotte F, Escanye JM, Walker P, Klein M, Robert J, Duc M (1992) Energetic metabolism in hypothyroid skeletal muscle, as studied by phosphorus magnetic resonance spectroscopy. J Clin Endocrinol Metab 74:124–129
Kan HE, Klomp DW, Wohlgemuth M, van Loosbroek-Wagemans I, van Engelen BG, Padberg GW, Heerschap A (2010) Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. NMR Biomed 23:563–568
Kemp GJ, Taylor DJ, Styles P, Radda GK (1993a) The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery. NMR Biomed 6:73–83
Kemp GJ, Taylor DJ, Thompson CH, Hands LJ, Rajagopalan B, Styles P, Radda GK (1993b) Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed 6:302–310
Kemp GJ, Hands LJ, Ramaswami G, Taylor DJ, Nicolaides A, Amato A, Radda GK (1995) Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy. Clin Sci 89:581–590
Kemp GJ, Roberts N, Bimson WE, Bakran A, Frostick SP (2002) Muscle oxygenation and ATP turnover when blood flow is impaired by vascular disease. Mol Biol Rep 29:187–191
Kemp GJ, Tonon C, Malucelli E, Testa C, Liava A, Manners D, Trevisi E, Martinuzzi A, Barbiroli B, Lodi R (2009) Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle’s disease. Eur J Appl Physiol 105:687–694
Kent-Braun JA (2009) Skeletal muscle fatigue in old age: whose advantage? Exerc Sport Sci Rev 37:3–9
Kent-Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG (1993) Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 43:125–131
Kent-Braun JA, Sharma KR, Miller RG, Weiner MW (1994) Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis. Muscle Nerve 17:835–841
Kent-Braun JA, Ng AV, Doyle JW, Towse TF (2002) Human skeletal muscle responses vary with age and gender during fatigue due to incremental isometric exercise. J Appl Physiol 93:1813–1823
Khushu S, Rana P, Sekhri T, Sripathy G, Tripathi RP (2010) Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study. Magn Reson Imaging 28:683–689
Ko SF, Huang CC, Hsieh MJ, Ng SH, Lee CC, Lee CC, Lin TK, Chen MC, Lee L (2008) 31P MR spectroscopic assessment of muscle in patients with myasthenia gravis before and after thymectomy: initial experience. Radiology 247:162–169
Kohler SJ, Yen Y, Wolber J, Chen AP, Albers MJ, Bok R, Zhang V, Tropp J, Nelson S, Vigneron DB, Kurhanewicz J, Hurd RE (2007) In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate. Magn Reson Med 58:65–69
Kornblum C, Schroder R, Muller K, Vorgerd M, Eggers J, Bogdanow M, Papassotiropoulos A, Fabian K, Klockgether T, Zange J (2005) Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur J Neurol 12:300–309
Kozak-Reiss G (1989) New research on muscular function: NMR spectroscopy. Application to malignant hyperthermia. Ann Fr Anesth Reanim 8:400–405
Kozak-Reiss G, Gascard JP, Redouane-Benichou K (1986) Detection of peranesthetic malignant hyperthermia by muscle contracture tests and NMR spectroscopy. Ann Fr Anesth Reanim 5:584–589
Kreis R, Brügger K, Skjelsvik C, Zwicky S, Ith M, Jung B, Baumgartner I, Boesch C (2001) Quantitative 1H magnetic resonance spectroscopy of myoglobin de- and re-oxygenation in skeletal muscle: reproducibility and effects of localization and disease. Magn Reson Med 46:240–248
Krssak M, Petersen KF, Dresner A, DiPietro L, Vogel SM, Rothman DL, Shulman GI, Roden M (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116
Kuhl CK, Layer G, Traeber F, Zierz S, Block W, Reiser M (1994) Mitochondrial encephalomyopathy: correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology 192:223–230
Kuo GP, Carrino JA (2007) Skeletal muscle imaging and inflammatory myopathies. Curr Opin Rheumatol 19:530–535
Kurhanewicz J, Vigneron DB, Brindle K, Chekmenev EY, Comment A, Cunningham CH, Deberardinis RJ, Green GG, Leach MO, Rajan SS, Rizi RR, Ross BD, Warren WS, Malloy CR (2011) Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 13:81–97
Kushnir T, Knubovets T, Itzchak Y, Eliav U, Sadeh M, Rapoport L, Kott E, Navon G (1997) In vivo 23Na NMR studies of myotonic dystrophy. Magn Reson Med 37:192–196
Kutsuzawa T, Shioya S, Kurita D, Haida M, Ohta Y, Yamabayashi H (1995) Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study. Am J Respir Crit Care Med 152:647–652
Labrune P, Jehenson P, Syrota A, Odievre M (1992) In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease. J Inherit Metab Dis 15:723–726
Lane RJ, Barrett MC, Taylor DJ, Kemp GJ, Lodi R (1998) Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscul Disord 8:204–209
Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21:543–559
Larson PE, Gold GE (2011) Science to practice: can inflammatory arthritis be monitored by using MR imaging with injected hyperpolarized 13C-pyruvate? Radiology 259:309–310
Lee S, Boesch C, Kuk JL, Arslanian S (2013) Effects of an overnight intravenous lipid infusion on intramyocellular lipid content and insulin sensitivity in African-American versus Caucasian adolescents. Metabolism 62:417–423
Leroy-Willig A, Fromes Y, Paturneau-Jouas M, Carlier P (2003) Assessing gene and cell therapies applied in striated skeletal and cardiac muscle: is there a role for nuclear magnetic resonance? Neuromuscul Disord 13:397–407
Levy P, Wuyam B, Pepin JL, Reutenauer H, Payen JF (1997) Skeletal muscle abnormalities in chronic obstructive lung disease with respiratory insufficiency. Value of P31 magnetic resonance spectroscopy. Rev Mal Respir 14:183–191
Lewis SF, Haller RG, Cook JD, Nunnally RL (1985) Muscle fatigue in McArdle’s disease studied by 31P-NMR: effect of glucose infusion. J Appl Physiol 59:1991–1994
Lindquist D (2008) What can 31P MR spectroscopy tell us about muscle disease? Radiology 247:1–2
Liska D, Dufour S, Zern TL, Taksali S, Cali AM, Dziura J, Shulman GI, Pierpont BM, Caprio S (2007) Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents. PLoS One 2:e569
Ljungberg M, Sunnerhagen KS, Vikhoff-Baaz B, Starck G, Forssell-Aronsson E, Hedberg M, Ekholm S, Grimby G (2003) 31P MRS evaluation of fatigue in anterior tibial muscle in postpoliomyelitis patients and healthy volunteers. Clin Physiol Funct Imaging 23:190–198
Lodi R, Montagna P, Iotti S, Zaniol P, Barboni P, Puddu P, Barbiroli B (1994) Brain and muscle energy metabolism studied in vivo by 31P-magnetic resonance spectroscopy in NARP syndrome. J Neurol Neurosurg Psychiatry 57:1492–1496
Lodi R, Muntoni F, Taylor J, Kumar S, Sewry CA, Blamire A, Styles P, Taylor DJ (1997a) Correlative MR imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy. Neuromuscul Disord 7:505–511
Lodi R, Taylor DJ, Tabrizi SJ, Kumar S, Sweeney M, Wood NW, Styles P, Radda GK, Schapira AH (1997b) In vivo skeletal muscle mitochondrial function in Leber’s hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy. Ann Neurol 42:573–579
Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ, Schapira AH (1999a) Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 96:11492–11495
Lodi R, Kemp GJ, Muntoni F, Thompson CH, Rae C, Taylor J, Styles P, Taylor DJ (1999b) Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study. Brain 122:121–130
Lodi R, Hart PE, Rajagopalan B, Taylor DJ, Crilley JG, Bradley JL, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM (2001) Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich’s ataxia. Ann Neurol 49:590–596
Machann J, Schick F, Jacob S, Lutz O, Häring HU, Claussen CD (1998) MR-spectroscopic determination of extra- and intramyocellular lipids in human calf muscle and correlation with insulin sensitivity. Magn Reson Mater Phy 6-Suppl1: 220
Machann J, Stefan N, Schick F (2008) (1)H MR spectroscopy of skeletal muscle, liver and bone marrow. Eur J Radiol 67:275–284
MacKenzie JD, Yen YF, Mayer D, Tropp JS, Hurd RE, Spielman DM (2011) Detection of inflammatory arthritis by using hyperpolarized 13C-pyruvate with MR imaging and spectroscopy. Radiology 259:414–420
Madsen M, Krusenstjerna-Hafstrom T, Moller L, Christensen B, Vendelbo MH, Pedersen SB, Frystyk J, Jessen N, Hansen TK, Stodkilde-Jorgensen H, Flyvbjerg A, Jorgensen JO (2012) Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial. J Clin Endocrinol Metab 97:1227–1235
Maillefert JF, Eicher JC, Walker P, Dulieu V, Rouhier-Marcer I, Branly F, Cohen M, Brunotte F, Wolf JE, Casillas JM, Didier JP (1998) Effects of low-frequency electrical stimulation of quadriceps and calf muscles in patients with chronic heart failure. J Cardiopulm Rehabil 18:277–282
Mancini DM, Wilson JR, Bolinger L, Li H, Kendrick K, Chance B, Leigh JS (1994) In vivo magnetic resonance spectroscopy measurement of deoxymyoglobin during exercise in patients with heart failure. Demonstration of abnormal muscle metabolism despite adequate oxygenation. Circulation 90:500–508
Martinuzzi A, Liava A, Trevisi E, Frare M, Tonon C, Malucelli E, Manners D, Kemp GJ, Testa C, Barbiroli B, Lodi R (2008) Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle’s disease. Muscle Nerve 37:350–357
Massa R, Lodi R, Barbiroli B, Servidei S, Sancesario G, Manfredi G, Zaniol P, Bernardi G (1996) Partial block of glycolysis in late-onset phosphofructokinase deficiency myopathy. Acta Neuropathol 91:322–329
Massie B, Conway M, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G, Rajagopalan B (1987a) Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76:1009–1019
Massie BM, Conway M, Yonge R, Frostick S, Sleight P, Ledingham J, Radda G, Rajagopalan B (1987b) 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 60:309–315
Massie BM, Conway M, Rajagopalan B, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G (1988) Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 78:320–326
Mattei JP, Bendahan D, Cozzone P (2004) P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases. Reumatismo 56:9–14
Matthews PM, Berkovic SF, Shoubridge EA, Andermann F, Karpati G, Carpenter S, Arnold DL (1991) In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF). Ann Neurol 29:435–438
Matthews PM, Ford B, Dandurand RJ, Eidelman DH, O’Connor D, Sherwin A, Karpati G, Andermann F, Arnold DL (1993) Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 43:884–890
McCully KK, Argov Z, Boden BP, Brown RL, Bank WJ, Chance B (1988) Detection of muscle injury in humans with 31-P magnetic resonance spectroscopy. Muscle Nerve 11:212–216
McCully KK, Forciea MA, Hack LM, Donlon E, Wheatley RW, Oatis CA, Goldberg T, Chance B (1991) Muscle metabolism in older subjects using 31P magnetic resonance spectroscopy. Can J Physiol Pharmacol 69:576–580
McCully KK, Fielding RA, Evans WJ, Leigh JS Jr, Posner JD (1993) Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. J Appl Physiol 75:813–819
McCully KK, Natelson BH, Iotti S, Sisto S, Leigh JS Jr (1996) Reduced oxidative muscle metabolism in chronic fatigue syndrome. Muscle Nerve 19:621–625
McCully KK, Smith S, Rajaei S, Leigh JS, Natelson BH (2003) Blood flow and muscle metabolism in chronic fatigue syndrome. Clin Sci 104:641–647
Meyer RA, Kushmerick MJ, Brown TR (1982) Application of 31P-NMR spectroscopy to the study of striated muscle metabolism. Am J Physiol 242:C1–C11
Miller RG (2002) Role of fatigue in limiting physical activities in humans with neuromuscular diseases. Am J Phys Med Rehabil 81:S99–S107
Miller RG, Boska MD, Moussavi RS, Carson PJ, Weiner MW (1988) 31P nuclear magnetic resonance studies of high energy phosphates and pH in human muscle fatigue. Comparison of aerobic and anaerobic exercise. J Clin Invest 81:1190–1196
Minotti JR, Johnson EC, Hudson TL, Zuroske G, Murata G, Fukushima E, Cagle TG, Chick TW, Massie BM, Icenogle MV (1990) Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 86:751–758
Mizuno M, Quistorff B, Theorell H, Theorell M, Chance B (1997) Effects of oral supplementation of coenzyme Q10 on 31P-NMR detected skeletal muscle energy metabolism in middle-aged post-polio subjects and normal volunteers. Mol Aspects Med 18:S291–S298
Mole PA, Chung Y, Tran TK, Sailasuta N, Hurd R, Jue T (1999) Myoglobin desaturation with exercise intensity in human gastrocnemius muscle. Am J Physiol 277:R173–R180
Montain SJ, Smith SA, Mattot RP, Zientara GP, Jolesz FA, Sawka MN (1998) Hypohydration effects on skeletal muscle performance and metabolism: a 31P-MRS study. J Appl Physiol 84:1889–1894
Moon RB, Richards JH (1973) Determination of intracellular pH by 31P magnetic resonance. J Biol Chem 248:7276–7278
Negendank W (1992) Studies of human tumors by MRS: a review. NMR Biomed 5:303–324
Newman ED, Kurland RJ (1992) P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Altered energy utilization during exercise. Arthritis Rheum 35:199–203
Newman RJ, Bore PJ, Chan L, Gadian DG, Styles P, Taylor D, Radda GK (1982) Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br Med J 284:1072–1074
Okuma H, Kurita D, Ohnuki T, Haida M, Shinohara Y (2007) Muscle metabolism in patients with polymyositis simultaneously evaluated by using 31P-magnetic resonance spectroscopy and near-infrared spectroscopy. Int J Clin Pract 61:684–689
Olgin J, Argov Z, Rosemberg H, Tuchler M, Chance B (1988) Non-invasive evaluation of malignant hyperthermia susceptiblity with phosphorus nuclear magnetic resonance spectroscopy. Anesthesiology 68:507–513
Olgin J, Rosenberg H, Allen G, Seestedt R, Chance B (1991) A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility. Anesth Analg 72:36–47
Pan JW, Hamm JR, Hetherington HP, Rothman DL, Shulman RG (1991) Correlation of lactate and pH in human skeletal muscle after exercise by 1H NMR. Magn Reson Med 20:57–65
Park JH, Vansant JP, Kumar NG, Gibbs SJ, Curvin MS, Price RR, Partain CL, James AE (1990) Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease. Radiology 177:473–479
Park JH, Olsen NJ, King L, Vital T, Buse R, Kari S, Hernanz-Schulman M, Price RR (1995) Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 38:68–77
Park JH, Kari S, King LE Jr, Olsen NJ (1998a) Analysis of 31P MR spectroscopy data using artificial neural networks for longitudinal evaluation of muscle diseases: dermatomyositis. NMR Biomed 11:245–256
Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ (1998b) Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum 41:406–413
Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, Hernanz-Schulman M, Olsen NJ (2000) Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum 43:2359–2367
Parry A, Matthews PM (2003) Roles for imaging in understanding the pathophysiology, clinical evaluation, and management of patients with mitochondrial disease. J Neuroimaging 13:293–302
Payen JF, Bosson JL, Bourdon L, Jacquot C, Le Bas JF, Stieglitz P, Benabid AL (1993) Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy. Anesthesiology 78:848–855
Pedersen BL, Baekgaard N, Quistorff B (2009) Muscle mitochondrial function in patients with type 2 diabetes mellitus and peripheral arterial disease: implications in vascular surgery. Eur J Vasc Endovasc Surg 38:356–364
Penn AM, Lee JW, Thuillier P, Wagner M, Maclure KM, Menard MR, Hall LD, Kennaway NG (1992) MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 42:2147–2152
Penn AM, Roberts T, Hodder J, Allen PS, Zhu G, Martin WR (1995) Generalized mitochondrial dysfunction in Parkinson’s disease detected by magnetic resonance spectroscopy of muscle. Neurology 45:2097–2099
Perseghin G, Price TB, Petersen KF, Roden M, Cline GW, Gerow K, Rothman DL, Shulman GI (1996) Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335:1357–1362
Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606
Petersen KF, Shulman GI (2006) New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy. Obesity 14(Suppl 1):34S–40S
Petersen KF, Hendler R, Price T, Perseghin G, Rothman DL, Held N, Amatruda JM, Shulman GI (1998) 13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes 47:381–386
Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671
Pfleiderer B, Lange J, Loske KD, Sunderkotter C (2004) Metabolic disturbances during short exercises in dermatomyositis revealed by real-time functional 31P magnetic resonance spectroscopy. Rheumatology 43:696–703
Phielix E, Mensink M (2008) Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol Behav 94:252–258
Phielix E, Szendroedi J, Roden M (2011) Mitochondrial function and insulin resistance during aging—a mini-review. Gerontology 57:387–396
Philip PA, Thompson CH, Carmichael J, Rea D, Mitchell K, Taylor DJ, Stuart NS, Dennis I, Rajagopalan B, Ganesan T (1993) A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy. Cancer Res 53:5649–5653
Pola A, Sadananthan SA, Yaligar J, Nagarajan V, Han W, Kuchel PW, Velan SS (2012) Skeletal muscle lipid metabolism studied by advanced magnetic resonance spectroscopy. Prog NMR Spectroscopy 65:66–76
Price TB, Krishnan-Sarin S, Rothman DL (2003) Smoking impairs muscle recovery from exercise. Am J Physiol 285:E116–E122
Propper DJ, Braybrooke JP, Taylor DJ, Lodi R, Styles P, Cramer JA, Collins WC, Levitt NC, Talbot DC, Ganesan TS, Harris AL (1999) Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours. Ann Oncol 10:923–927
Quistorff B, Johansen L, Sahlin K (1993) Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Biochem J 291:681–686
Radda GK, Bore PJ, Gadian DG, Ross BD, Styles P, Taylor DJ, Morgan-Hughes J (1982) 31P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature 295:608–609
Reeves RR (1996) Effects of thyroid hormone treatment on 31P-NMR spectroscopy of muscle and on nerve conduction studies in a patient with long-standing severe hypothyroidism. J Am Osteopath Assoc 96:424–428
Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M, Falconer-Smith J (1981) Examination of a case of suspected McArdle’s syndrome by 31P nuclear magnetic resonance. N Engl J Med 304:1338–1342
Rothman DL, Shulman RG, Shulman GI (1992) 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89:1069–1075
Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI (1995) Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 92:983–987
Rotman S, Slotboom J, Kreis R, Boesch C, Jequier E (2000) Muscle glycogen recovery after exercise measured by 13C-MRS in humans: effect of nutritional solutions. Magn Reson Mater Phys 11:114–121
Salerno C, Iotti S, Lodi R, Crifo C, Barbiroli B (1997) Failure of muscle energy metabolism in a patient with adenylosuccinate lyase deficiency. An in vivo study by phosphorus NMR spectroscopy. Biochim Biophys Acta 1360:271–276
Sato T, Katabami T, Furukawa K, Narimatsu H, Hashimoto T, Nakajima Y, Ohta A, Sasaoka T, Tanaka Y (2012) Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone deficiency without diabetes mellitus. Obes Res Clin Pract 6:e321–e329
Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520
Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K (2003) Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107:3040–3046
Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O (1993) Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29:158–167
Schocke MF, Esterhammer R, Ostermann S, Santner W, Gorny O, Fraedrich G, Jaschke WR, Greiner A (2006) High-energy phosphate metabolism during calf ergometry in patients with isolated aorto-iliac artery stenoses. Invest Radiol 41:874–882
Schocke M, Esterhammer R, Greiner A (2008) High-energy phosphate metabolism in the exercising muscle of patients with peripheral arterial disease. Vasa 37:199–210
Schröder L, Weber MA, Ulrich M, Regula JU (2006) Metabolic imaging of atrophic muscle tissue using appropriate markers in 1H and 31P NMR spectroscopy. Neuroradiology 48:809–816
Schroers A, Kley RA, Stachon A, Horvath R, Lochmuller H, Zange J, Vorgerd M (2006) Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency. Neurology 66:285–286
Schunk K, Romaneehsen B, Rieker O, Duber C, Kersjes W, Schadmand-Fischer S, Schmiedt W, Thelen M (1998) Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: effects of vascular therapy on spectroscopic results. Invest Radiol 33:329–335
Seo Y, Murakami M, Watari H, Imai Y, Yoshizaki K, Nishikawa H, Moromoto T (1983) Intracellular pH determination by a 31P-NMR technique. The second dissociation constant of phosphoric acid in a biological system. J Biochem 94:729–734
Sharma U, Kumar V, Wadhwa S, Jagannathan NR (2007) In vivo (31)P MRS study of skeletal muscle metabolism in patients with postpolio residual paralysis. Magn Reson Imaging 25:244–249
Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223–228
Siciliano G, Rossi B, Martini A, Angelini C, Martinuzzi A, Lodi R, Zaniol P, Barbiroli B, Muratorio A (1995) Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy. J Neurol Sci 128:84–91
Simms RW, Roy SH, Hrovat M, Anderson JJ, Skrinar G, LePoole SR, Zerbini CA, de Luca C, Jolesz F (1994) Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 37:794–800
Sivakumar K, Vasconcelos O, Goldfarb L, Dalakas MC (1996) Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation. Neurology 46:1337–1342
Subhawong TK, Wang X, Durand DJ, Jacobs MA, Carrino JA, Machado AJ, Fayad LM (2012) Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. AJR Am J Roentgenol 198:162–172
Taivassalo T, De Stefano N, Argov Z, Matthews PM, Chen J, Genge A, Karpati G, Arnold DL (1998) Effects of aerobic training in patients with mitochondrial myopathies. Neurology 50:1055–1060
Taivassalo T, De SN, Chen J, Karpati G, Arnold DL, Argov Z (1999) Short-term aerobic training response in chronic myopathies. Muscle Nerve 22:1239–1243
Tarnopolsky M (2012) Exercise testing in metabolic myopathies. Phys Med Rehabil Clin N Am 23:173–86, xii
Tarnopolsky MA, Raha S (2005) Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc 37:2086–2093
Taylor DJ (2000) Clinical utility of muscle MR spectroscopy. Semin Musculoskelet Radiol 4:481–502
Taylor DJ, Bore PJ, Styles P, Gadian DG, Radda GK (1983) Bioenergetics of intact human muscle: a 31P nuclear magnetic resonance study. Mol Biol Med 1:77–94
Taylor DJ, Styles P, Matthews PM, Arnold DA, Gadian DG, Bore P, Radda GK (1986) Energetics of human muscels: exercise-induced ATP depletion. Magn Reson Med 3:44–54
Taylor DJ, Rajagopalan B, Radda GK (1992) Cellular energetics in hypothyroid muscle. Eur J Clin Invest 22:358–365
Taylor DJ, Kemp GJ, Woods CG, Edwards JH, Radda GK (1993) Skeletal muscle bioenergetics in myotonic dystrophy. J Neurol Sci 116:193–200
Taylor DJ, Krige D, Barnes PR, Kemp GJ, Carroll MT, Mann VM, Cooper JM, Marsden CD, Schapira AH (1994) A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson’s disease. J Neurol Sci 125:77–81
Taylor DJ, Amato A, Hands LJ, Kemp GJ, Ramaswami G, Nicolaides A, Radda GK (1996) Changes in energy metabolism of calf muscle in patients with intermittent claudication assessed by 31P magnetic resonance spectroscopy: a phase II open study. Vasc Med 1:241–245
Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M (2007) Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus. Metabolism 56:1418–1424
Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, Claussen C, Jacob S, Schick F, Haring HU, Stumvoll M (2003) Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88:1785–1791
Thompson CH, Davies RJ, Kemp GJ, Taylor DJ, Radda GK, Rajagopalan B (1993) Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure. Thorax 48:486–490
Thompson CH, Kemp GJ, Barnes PR, Rajagopalan B, Styles P, Taylor DJ, Radda GK (1994) Uraemic muscle metabolism at rest and during exercise. Nephrol Dial Transplant 9:1600–1605
Thompson CH, Macaulay VM, O’Byrne KJ, Kemp GJ, Wilner SM, Talbot DC, Harris AL, Radda GK (1996) Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply. Br J Cancer 73:1161–1165
Torriani M, Townsend E, Thomas BJ, Bredella MA, Ghomi RH, Tseng BS (2012) Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal Radiol 41:437–445
Tosetti M, Linsalata S, Battini R, Volpi L, Cini C, Presciutti O, Muntoni F, Cioni G, Siciliano G (2011) Muscle metabolic alterations assessed by 31-phosphorus magnetic resonance spectroscopy in mild Becker muscular dystrophy. Muscle Nerve 44:816–819
Trenell MI, Sue CM, Kemp GJ, Sachinwalla T, Thompson CH (2006a) Aerobic exercise and muscle metabolism in patients with mitochondrial myopathy. Muscle Nerve 33:524–531
Trenell MI, Thompson CH, Sue CM (2006b) Exercise and myotonic dystrophy: a 31P magnetic resonance spectroscopy and magnetic resonance imaging case study. Ann Neurol 59:871–872
Trenell MI, Sue CM, Thompson CH, Kemp GJ (2007) Supplemental oxygen and muscle metabolism in mitochondrial myopathy patients. Eur J Appl Physiol 99:541–547
Trepp R, Fluck M, Stettler C, Boesch C, Ith M, Kreis R, Hoppeler H, Howald H, Schmid JP, Diem P, Christ ER (2008) Effect of growth hormone (GH) on human skeletal muscle lipid metabolism in GH-deficiency. Am J Physiol 294:E1127–E1134
van Elderen SG, Doornbos J, van Essen EH, Lemkes HH, Maassen JA, Smit JW, De Roos A (2009) Phosphorus-31 magnetic resonance spectroscopy of skeletal muscle in maternally inherited diabetes and deafness A3243G mitochondrial mutation carriers. J Magn Reson Imaging 29:127–131
van Tienen FH, Praet SF, De Feyter HM, van den Broek NM, Lindsey PJ, Schoonderwoerd KG, de Coo I, Nicolay K, Prompers JJ, Smeets HJ, van Loon LJ (2012) Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J Clin Endocrinol Metab 97:3261–3269
Vanderthommen M, Duteil S, Wary C, Raynaud JS, Leroy-Willig A, Crielaard JM, Carlier PG (2003) A comparison of voluntary and electrically induced contractions by interleaved 1H- and 31P-NMRS in humans. J Appl Physiol 94:1012–1024
Vermathen P, Saillen P, Boss A, Zehnder M, Boesch C (2012) Skeletal muscle 1H MRSI before and after prolonged exercise I. muscle specific depletion of intramyocellular lipids. Magn Reson Med 68:1357–1367
Vissing J, Vissing SF, MacLean DA, Saltin B, Quistorff B, Haller RG (1998) Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies. J Clin Invest 101:1654–1660
Vita G, Toscano A, Bresolin N, Meola G, Fortunato F, Baradello A, Barbiroli B, Frassineti C, Zaniol P, Messina C (1994) Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: biochemistry, muscle culture and 31P-MR spectroscopy. J Neurol 241:289–294
Vorgerd M, Zange J (2002) Carbohydrate oxidation disorders of skeletal muscle. Curr Opin Clin Nutr Metab Care 5:611–617
Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, Bruns N, Fabian K, Tegenthoff M, Mortier W, Luttmann A, Zange J, Malin JP (2000) Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol 57:956–963
Vorgerd M, Kilimann MW, Zange J, Malin JP (2002a) Muskelglykogenosen. Dtsch Ärzteblatt 99:A2328–A2340
Vorgerd M, Zange J, Kley R, Grehl T, Husing A, Jager M, Muller K, Schroder R, Mortier W, Fabian K, Malin JP, Luttmann A (2002b) Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Arch Neurol 59:97–101
Walker UA (2008) Imaging tools for the clinical assessment of idiopathic inflammatory myositis. Curr Opin Rheumatol 20:656–661
Wang Z, Noyszewski EA, Leigh JS (1990) In vivo MRS measurement of deoxymyoglobin in human forearms. Magn Reson Med 14:562–567
Wang X, Jacobs MA, Fayad L (2011) Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI. NMR Biomed 24:750–763
Wary C, Laforet P, Eymard B, Fardeau M, Leroy-Willig A, Bassez G, Leroy JP, Caillaud C, Poenaru L, Carlier PG (2003) Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency. Neuromuscul Disord 13:545–553
Wary C, Nadaj-Pakleza A, Laforet P, Claeys KG, Carlier R, Monnet A, Fleury S, Baligand C, Eymard B, Labrune P, Carlier PG (2010) Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy. Neuromuscul Disord 20:548–558
Weber MA, Essig M, Kauczor HU (2007) Radiological diagnostics of muscle diseases. Fortschr Röntgenstr 179:712–720
Weber MA, Krakowski-Roosen H, Schroder L, Kinscherf R, Krix M, Kopp-Schneider A, Essig M, Bachert P, Kauczor HU, Hildebrandt W (2009) Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol 48:116–124
Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S (2003) Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362:951–957
Weissman JD, Constantinitis I, Hudgins P, Wallace DC (1992) 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients. Neurology 42:619–623
Wells GD, Noseworthy MD, Hamilton J, Tarnopolski M, Tein I (2008) Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome. Can J Neurol Sci 35:31–40
Wells GD, Wilkes DL, Schneiderman JE, Rayner T, Elmi M, Selvadurai H, Dell SD, Noseworthy MD, Ratjen F, Tein I, Coates AL (2011) Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res 69:40–45
Wilhelm T, Bachert P (2001) In vivo 31P echo-planar spectroscopic imaging of human calf muscle. J Magn Reson 149:126–130
Wilson JR, Fink L, Maris J, Ferraro N, Power-Vanwart J, Eleff S, Chance B (1985) Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 71:57–62
Wong R, Lopaschuk G, Zhu G, Walker D, Catellier D, Burton D, Teo K, Collins-Nakai R, Montague T (1992) Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest 102:1716–1722
Wray DW, Nishiyama SK, Monnet A, Wary C, Duteil S, Carlier PG, Richardson RS (2009a) Multiparametric NMR-based assessment of skeletal muscle perfusion and metabolism during exercise in elderly persons: preliminary findings. J Gerontol A Biol Sci Med Sci 64:968–974
Wray DW, Nishiyama SK, Monnet A, Wary C, Duteil SS, Carlier PG, Richardson RS (2009b) Antioxidants and aging: NMR-based evidence of improved skeletal muscle perfusion and energetics. Am J Physiol 297:H1870–H1875
Wu JS, Buettner C, Smithline H, Ngo LH, Greenman RL (2011) Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications. Muscle Nerve 43:76–81
Zange J, Grehl T, Disselhorst-Klug C, Rau G, Muller K, Schroder R, Tegenthoff M, Malin JP, Vorgerd M (2003) Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle’s disease: a noninvasive 31P-MRS and EMG study. Muscle Nerve 27:728–736
Zatina MA, Berkowitz HD, Gross GM, Maris JM, Chance B (1986) 31P nuclear magnetic resonance spectroscopy: noninvasive biochemical analysis of the ischemic extremity. J Vasc Surg 3:411–420
Zochodne DW, Koopman WJ, Witt NJ, Thompson T, Driedger AA, Gravelle D, Bolton CF (1992) Forearm P-31 nuclear magnetic resonance spectroscopy studies in oculopharyngeal muscular dystrophy. Can J Neurol Sci 19:174–179
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Boesch, C. (2013). MR Spectroscopy and Spectroscopic Imaging for Evaluation of Skeletal Muscle Metabolism: Basics and Applications in Metabolic Diseases. In: Weber, MA. (eds) Magnetic Resonance Imaging of the Skeletal Musculature. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_847
Download citation
DOI: https://doi.org/10.1007/174_2013_847
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37218-6
Online ISBN: 978-3-642-37219-3
eBook Packages: MedicineMedicine (R0)